Collaboration in Pharmaceutical Logistics and Food Businesses through a Capital and Business Alliance with Medipal
First written in FY2022-Q3. 1 of 2 entries say "Advanced", first in FY2022. Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022AdvancedAnnual report
「Payment for the Third-Party Allotment Capital Increase was completed on 6 January 2022. The Company plans to advance the enhancement of distribution functions for prescription pharmaceuticals and other products, the establishment of distribution systems, and collaboration in the food-related business.」
Payment for the third-party allotment under the capital and business alliance with MEDIPAL was completed, and 208,500 shares were issued for a total of ¥170,761,500. Specific areas of collaboration include expanding the use of the G-TAG series in pharmaceutical and medical-device logistics and collaborating in the frozen-food business. - FY2022-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 21 December 2021, the Company resolved to enter into a capital and business alliance with MEDIPAL HOLDINGS CORPORATION (hereinafter, “MEDIPAL”) and to issue common shares to MEDIPAL through a third-party allotment (hereinafter, the “Third-Party Allotment Capital Increase”), and entered into a business alliance agreement on the same day. Payment for the Third-Party Allotment Capital Increase was completed on 6 January 2022.」
The Company decided to enter into a capital and business alliance with MEDIPAL and to advance collaboration in upgrading logistics functions and establishing distribution systems for pharmaceuticals, medical devices and other products, as well as in the food-related business. It issued 208,500 shares through a third-party allotment for a total of ¥170,761,500, with the aim of expanding the applications and enhancing the functions of the G-TAG series.